Medication for Opioid Use Disorder

DESCRIPTION

In conjunction with Anne Arundel County, the Central East ATTC is hosting a webinar to address Medication for Opioid Use Disorder (MOUD) and the best practices for prescribing. Buprenorphine will be one of the medications discussed during this presentation. Recent federal changes no longer require a waiver for providers to prescribe Buprenorphine so this training is for educational purposes only. 

PARTICIPANTS WILL

• Learn the waves of the current Opioid Epidemic.
• Understand how the MATE ACT 2022 should help.
• Learn the FDA-approved drugs for Opioid Use Disorder.
• Learn about methods of Harm reduction.

TARGET AUDIENCE

We would like to welcome MOUD prescribers, nurse practitioners, case managers, social workers, and other providers in hopes to increase the number of active MOUD prescribers and increase the knowledge, understanding, and value of MOUD treatment.

PRESENTER

Dr. Harry Haus, MD, received his education from distinguished universities in the region including Albany Medical College and the University of Pittsburgh among others. He has spent much of his career in Addiction Medicine and Family Medicine. He has led a Group Addiction Medicine practice since 2009 and is currently a certified medical review officer (MRO) for hospitals throughout New York and Pennsylvania. He has actively worked with our team at the Opioid Response Network (ORN) and has taught for the American Society for Addiction Medicine (ASAM) since 2019 to keep providing education to the field. In previous years, Dr. Haus was the Medical Director for USPS Eastern Area, Medical Director of CIGNA  Midwest, and lead investigator for the Nasal Flu Vaccine and first Shingles vaccine.